Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
09:00-15:30 | 09:00-15:30 |
All iLDLTG Council Members |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
15:30-16:30 | 15:30-16:30 |
Council Meeting |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
08:00-08:10 | 08:00-08:10 |
Opening Ceremony and Welcome Address by Congress President and iLDLT President |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker |
---|---|---|---|
08:10-08:30 | 08:10-08:30 |
Advancing Global Collaboration in LDLT |
Kim M. Olthoff [USA] |
08:30-08:50 | 08:30-08:50 |
Perspectives on Liver Transplantation: Innovation, Education, and Beyond |
Zhaolong Chen [Taiwan, China] |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
08:50-09:05 | 08:50-09:05 |
USA & North America |
Elizabeth Pomfret [USA] | |
09:05-09:20 | 09:05-09:20 |
Europe |
Jan Lerut [Belgium] | |
09:20-09:35 | 09:20-09:35 |
Japan |
Hiroto Egawa [Japan] | |
09:35-09:50 | 09:35-09:50 |
South Korea |
Kwang-Woong Lee [Republic of Korea] | |
09:50-10:05 | 09:50-10:05 |
India |
Subhash Gupta [India] | |
10:05-10:20 | 10:05-10:20 |
China |
Qiang Xia [China] | |
10:20-10:25 | 10:20-10:25 |
Q&A (5 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
10:25-10:40 | 10:25-10:40 |
Pure laparoscopic donor hepatectomy in LDLT |
Kwang-Woong Lee [Republic of Korea] | |
10:40-10:55 | 10:40-10:55 |
Robotic-assisted donor hepatectomy in LDLT |
Kamal Yadav [India] | |
10:55-11:10 | 10:55-11:10 |
How to establish a Robotic-assisted Donor Hepatectomy Program |
Fabrizio di Benedetto [Italy] | |
11:10-11:25 | 11:10-11:25 |
Bile Duct Division Techniques in MIDH |
Jongman Kim [Republic of Korea] | |
11:25-11:30 | 11:25-11:30 |
Q&A (5 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
11:30-11:45 | 11:30-11:45 |
Liver transplantation for hepatocellular carcinoma: surgical technique and innovations |
Shusen Zheng [China] | |
11:45-12:00 | 11:45-12:00 |
Recovered Diseased Liver Transplantation |
Jiahong Dong [China] | |
12:00-12:15 | 12:00-12:15 |
Perihilar cholangioCA and LT -- Between resection and LT |
Taizo Hibi [Japan] | |
12:15-12:30 | 12:15-12:30 |
Improving transplantibility for locally advanced HCC: the Hong Kong approach |
Albert Chi Yan Chan [Hong Kong, China] | |
12:30-12:45 | 12:30-12:45 |
LDLT vs DDLT in hepatobiliary oncology |
Tiffany Wong [Hong Kong, China] | |
12:45-12:50 | 12:45-12:50 |
Q&A (5 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
14:00-14:15 | 14:00-14:15 |
Pure laparoscopic LDLT Graft Implantation |
Gyu-Seong Choi [Republic of Korea] | |
14:15-14:30 | 14:15-14:30 |
Robotic-assisted LTx in recipient |
Dieter Broering [Saudi Arabia] | |
14:30-14:45 | 14:30-14:45 |
Complicated outflow reconstruction techniques in LDLT |
Deok-Bog Moon [Republic of Korea] | |
14:45-15:00 | 14:45-15:00 |
Complicated portal vein reconstruction in LDLT recipients |
Seisuke Sakamoto [Japan] | |
15:00-15:15 | 15:00-15:15 |
Complicated bile duct reconstruction in LDLT recipient |
Itsuko Chih-Yi Chen [Taiwan, China] | |
15:15-15:25 | 15:15-15:25 |
Q&A (10 min) |
||
15:25-15:30 | 15:25-15:30 |
Coffee Break |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
15:30-15:50 | 15:30-15:50 |
Group 1: Position and Port sites |
||
15:50-16:10 | 15:50-16:10 |
Group 2: Hilum dissection: portal vein, hepatic artery |
||
16:10-16:30 | 16:10-16:30 |
Group 3: Parenchymal hepatic transection |
||
16:30-16:50 | 16:30-16:50 |
Group 4: Bile duct division |
||
16:50-17:10 | 16:50-17:10 |
Group 5: Vascular division and graft out |
||
17:10-17:30 | 17:10-17:30 |
Group 6: Anesthesia and Pain control |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
14:00-14:15 | 14:00-14:15 |
Post-Liver Transplant Complications: Beyond Reiection and Recurrent Disease |
Hanlin Wang [USA] | |
14:15-14:30 | 14:15-14:30 |
Evolving Concepts in Liver Allograft Pathology: Insights from the Banff Liver Group |
Funda Yilmaz [Turkey] | |
14:30-14:45 | 14:30-14:45 |
Liver allograft rejection in living donor liver transplant (LDLT) recipients |
Mukul Vij [India] | |
14:45-15:00 | 14:45-15:00 |
Transplant Pathology in Xenotransplant |
Hui Guo [China] | |
15:00-15:10 | 15:00-15:10 |
Q&A (10 min) |
||
15:10-15:20 | 15:10-15:20 |
Coffee break |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
15:20-15:40 | 15:20-15:40 |
Steatosis assessment and application in donor liver |
DongJin Joo [Republic of Korea] | |
15:40-16:00 | 15:40-16:00 |
Long-term outcomes of LT recipients using Hepatitis virus-positive donor liver |
James Fung [Hong Kong, China] | |
16:00-16:20 | 16:00-16:20 |
From Assessment to Donation: Hepatologist’s Insights on Preparing Living Liver Donors |
selzner Nazia [Canada] | |
16:20-16:40 | 16:20-16:40 |
Strategies for expanding donor standards for split liver transplantation |
Shuhong Yi [China] | |
16:40-16:50 | 16:40-16:50 |
Q&A (10 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Use of AI in Liver Surgery and Liver Transplantation |
Jinsoo Rhu [Republic of Korea] | |
09:15-09:30 | 09:15-09:30 |
AI and Prediction of Outcomes in Transplantation |
Daniel G Maluf [USA] | |
09:30-09:45 | 09:30-09:45 |
Advances in Imaging Techniques in Liver to Achieve Precision Liver Surgery |
Gao Yujia [Singapore] | |
09:45-10:00 | 09:45-10:00 |
The prediction of hcc recurrence after liver transplantation based on radiomics |
Qi Ling [China] | |
10:00-10:15 | 10:00-10:15 |
Integrated, intelligent and international hospital establishment for higher quality clinical medical care |
Chunming Wang [China] | |
10:15-10:20 | 10:15-10:20 |
Q&A (5 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
10:20-10:35 | 10:20-10:35 |
Auxiliary Liver Xenograft for Acute Liver Failure |
Kefeng Dou [China] | |
10:35-10:50 | 10:35-10:50 |
Xenotransplantation- Where we are |
Abraham Shaked [USA] | |
10:50-11:05 | 10:50-11:05 |
Clinical pig to human liver xenotransplantation: how far do we have to go? |
Hongjiang Wei [China] | |
11:05-11:20 | 11:05-11:20 |
Xenotransplantation: current status and a perspective on the future |
Leo H. Bühler [Switzerland] | |
11:20-11:35 | 11:20-11:35 |
Emerging technologies in chimeric humanized organs |
Liangxue Lai [China] | |
11:35-11:40 | 11:35-11:40 |
Q&A (5 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
11:40-11:55 | 11:40-11:55 |
Advancing Domino Liver Transplantation: Challenges, Strategies, and Future Perspectives |
Robert Minnee [Netherlands] | |
11:55-12:10 | 11:55-12:10 |
Pros and Cons in Dual-graft Adult Living Donor Liver Transplantation |
DongHwan Jung [Republic of Korea] | |
12:10-12:25 | 12:10-12:25 |
New developments in liver autotransplantation |
Qian Lu [China] | |
12:25-12:40 | 12:25-12:40 |
Waste-to-Resource Strategy in Liver Transplantation: Utilizing Discarded Partial Hepatectomy Grafts |
Zhenbin Ding [China] | |
12:40-12:45 | 12:40-12:45 |
Q&A (5 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker |
---|---|---|---|
13:15-13:45 | 13:15-13:45 |
Optimizing immunosuppression: a path to consistency, innovation, and improved outcomes |
selzner Nazia [Canada] |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker |
---|---|---|---|
13:45-14:15 | 13:45-14:15 |
Tacrolimus in focus: Striking the optimal balance through data-driven care and personalization |
YoungRok Choi [Republic of Korea] |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
14:00-14:15 | 14:00-14:15 |
Liver transplantation – graft injury and cancer recurrence |
Nancy Kwan Man [Hong Kong, China] | |
14:15-14:30 | 14:15-14:30 |
Donor Quality, Preservation, and Short-Term Outcomes in Liver Transplant: A Single-Cell and Spatial Analysis of Ischemia-Reperfusion Injury |
Valeria R. Mas [USA] | |
14:30-14:45 | 14:30-14:45 |
EBV-reactive KIR+ CX3CR1+ CD8+ T cells mediate liver transplantation tolerance by targeting alloreactive CD4+ T cells |
Yongbo Liu [China] | |
14:45-15:00 | 14:45-15:00 |
The Dual Regulatory Roles of Macrophages in Acute Allogeneic Organ Graft Rejection |
Yong Zhao [China] | |
15:00-15:15 | 15:00-15:15 |
The role of MDSCs in tumor recurrence post LT |
Hui Liu [China] | |
15:15-15:25 | 15:15-15:25 |
Q&A (10 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker |
---|---|---|---|
15:30-15:37 | 15:30-15:37 |
Graft inflow modulation in living donor liver transplantation |
Baimakhanov Bolat [Kyrgyzstan] |
15:37-15:44 | 15:37-15:44 |
Impact of the High Baseline Anti-A/B Antibody titer on the clinical outcomes in ABO-incompatible Living Donor Liver Transplantation |
Hyelim Joo [Republic of Korea] |
15:44-15:51 | 15:44-15:51 |
SEVEN-DAY CREATININE: A CRYSTAL BALL FOR KIDNEY FATE AFTER LIVER TRANSPLANT |
Viraj Panda [India] |
15:51-15:58 | 15:51-15:58 |
Perioperative Management, Ethical Concerns, and Outcomes of Pediatric Domino Liver Transplants from Maple Syrup Urine Disease Donors |
Vipul Gautam [India] |
15:58-16:05 | 15:58-16:05 |
Evaluation Of Thrombocytopenia and Platelet Transfusion in Liver Transplant Recipients at a Quaternary Care Centre in South India |
Deepti Sachan [India] |
16:05-16:12 | 16:05-16:12 |
Peri-operative risk factors and outcomes in acute-on-chronic liver-failure (ACLF) patients undergoing living donor liver transplantation (LT) |
Vignesh Mani [India] |
16:12-16:19 | 16:12-16:19 |
Is a Functional Liver Remnant Volume Below 30% an Absolute Contraindication for Laparoscopic Living Liver Donors? |
Sukmin Gwon [Republic of Korea] |
16:19-16:26 | 16:19-16:26 |
The Infection Puzzle in Liver Transplantation: Risk Factors, Outcomes and Clinical Strategy |
Aninditha Guraza [India] |
16:26-16:33 | 16:26-16:33 |
Living Donor Liver Transplantation for Unresectable Colorectal Liver Metastasis – The University of Rochester Experience |
Roberto Hernandez-Alejandro [Mexico] |
16:33-16:40 | 16:33-16:40 |
Impact of Cold Ischemic Time on Rejection After Liver Transplantation: Is There a Safe Wondow? |
Sehyeon Yu [Republic of Korea] |
16:40-16:47 | 16:40-16:47 |
Antioxidant Therapy for Prevention of Ischemia-Reperfusion Injury in Living Donor Liver Transplantation |
Sitora Gulshanova [Tajikistan] |
16:47-16:54 | 16:47-16:54 |
Does GRWR Really Matters when Graft Weight is More than 650 gms in Living donor Liver Transplantation ???? |
hetal pampaniya [India] |
16:54-17:01 | 16:54-17:01 |
Global Outcomes of Open versus Laparoscopic versus Robotic Donor Hepatectomy: A Prospective Study from the International LDLT Registry (LDLTregistry.org) |
Dimitri A. Raptis [Saudi Arabia] |
17:01-17:08 | 17:01-17:08 |
Renal Recovery Benefit of Living Donor Compared to Deceased Donor Liver Transplantation in High-MELD(≥35) Recipients: A Propensity Score-Matched Study |
Sung-Min Kim [Republic of Korea] |
17:08-17:15 | 17:08-17:15 |
Clinical heterogeneity of refractory ascites after pediatric liver transplantation modulates allograft rejection risk |
Bingran Wang [China] |
17:15-17:22 | 17:15-17:22 |
Mapping the Immunometabolic Landscape: Dual Axes of CCL3-Driven Macrophage Polarization and Succinate Signaling Drive Fibrosis in Pediatric Liver Transplant Recipients |
Zhixin Zhang [China] |
17:22-17:29 | 17:22-17:29 |
Circadian Timing of Liver Transplantation Influences the Rejection Related Injury: A Retrospective Cohort Study |
Jiaqi Song [China] |
17:29-17:36 | 17:29-17:36 |
Mechanism of liver circFADS2 inhibiting rejection after liver transplantation in children |
Qi Pan [China] |
17:36-17:43 | 17:36-17:43 |
Systematic Evaluation of Broad-PAM High-Fidelity Adenine Base Editors |
Yiqing Zhang [China] |
17:43-17:50 | 17:43-17:50 |
CRKP/MRSA Colonization Predicts Early Post-Liver Transplant Infection in Children: A Retrospective Matched Cohort Study |
Chenling Ding [China] |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
09:00-09:05 | 09:00-09:05 |
Opening Remarks |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
09:05-09:25 | 09:05-09:25 |
Roles of AI in Peri-operative Management of HCC |
Alfred Kow Wei Chieh [Singapore] | |
09:25-09:45 | 09:25-09:45 |
AI-driven New Breakthroughs in the Precise Diagnosis and Treatment of HCC |
Hong Shen [China] | |
09:45-10:00 | 09:45-10:00 |
Panel Discussion: Toward Precision Diagnosis and Treatment in HCC |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
10:00-10:20 | 10:00-10:20 |
A New Paradigm of Conversion Therapy for HCC in the Immunotherapy Era |
Yinghong Shi [China] | |
10:20-10:40 | 10:20-10:40 |
The Value and Significance of TALENTACE |
Zhiyuan Wu [China] | |
10:40-10:55 | 10:40-10:55 |
Panel Discussion: Integrated Strategies for Better Outcomes |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
10:55-11:00 | 10:55-11:00 |
Closing Remarks |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker |
---|---|---|---|
11:00-11:30 | 11:00-11:30 |
Chinese guideline for clinical application of antithymocyte globulin in liver transplant recipients |
Li Zhuang [China] |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
12:00-12:15 | 12:00-12:15 |
Opening |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
12:10-12:25 | 12:10-12:25 |
TBD |
Guangming Li [China] | |
12:25-12:40 | 12:25-12:40 |
Creation and Application of New Techniques for Simultaneous Liver-Kidney Transplantation (SLKT) |
Xuyong Sun [China] | |
12:40-12:55 | 12:40-12:55 |
Tips of Vessel Transection in Minimally Invasive Donor Hepatectomy |
yi luo [China] | |
12:55-13:10 | 12:55-13:10 |
Discussion |
||
13:10-13:25 | 13:10-13:25 |
Endo Lab |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
13:25-13:40 | 13:25-13:40 |
Standardized treatments of intrahepatic cholangiocarcinoma |
Yinghong Shi [China] | |
13:40-13:55 | 13:40-13:55 |
Exploration of liver transplantation for liver cancer |
Sheng Yan [China] | |
13:55-14:10 | 13:55-14:10 |
Sharing the construction experience of the AI empowered liver cancer center |
Gang Chen [China] | |
14:10-14:25 | 14:10-14:25 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
14:25-14:30 | 14:25-14:30 |
Closing Remarks |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
15:00-15:10 | 15:00-15:10 |
Opening Speech |
||
15:10-15:30 | 15:10-15:30 |
Use of Immune Induction in Split Liver Transplantation |
Shuhong Yi [China] | |
15:30-15:50 | 15:30-15:50 | Li Zhuang [China] | ||
15:50-16:10 | 15:50-16:10 |
Panel discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
16:20-16:40 | 16:20-16:40 | Xianghui Wang [China] | ||
16:40-17:00 | 16:40-17:00 | Cheng Yang [China] | ||
17:00-17:20 | 17:00-17:20 |
Panel discussion |
||
17:20-17:40 | 17:20-17:40 |
Closing |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
08:30-08:45 | 08:30-08:45 |
LDLT Inflow Modification |
James Pomposelli [USA] | |
08:45-09:00 | 08:45-09:00 |
How do we management SFSS in LDLT |
Toru Ikegami [Japan] | |
09:00-09:15 | 09:00-09:15 |
Forewarning and surgical strategies for LFSS |
Jiayin Yang [China] | |
09:15-09:30 | 09:15-09:30 |
Living-related donors for hereditary liver disease Yes or No |
Ping Wan [China] | |
09:30-09:40 | 09:30-09:40 |
Q&A (10 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
09:40-09:55 | 09:40-09:55 |
ABO-i LDLT in Children |
Mureo Kasahara [Japan] | |
09:55-10:10 | 09:55-10:10 |
Hepatoblastoma and LT in Children |
Hongting Huang [China] | |
10:10-10:25 | 10:10-10:25 |
Indication of liver transplantation for metabolic liver disease in pediatric patients |
Gomathy Narasimhan [India] | |
10:25-10:40 | 10:25-10:40 |
Auxiliary Liver Transplantation for the Treatment of Acute Liver Failure in Children |
Zhijun Zhu [China] | |
10:40-10:50 | 10:40-10:50 |
Q&A (10 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker |
---|---|---|---|
12:25-12:40 | 12:25-12:40 |
Subsegment-based lCG fluorescence-quided laparoscopic anatomic hepatectomy |
Xiaoying Wang [China] |
12:40-12:55 | 12:40-12:55 |
Comprehensive Management of Bleeding Prevention in Liver Transplantation |
Zhenbin Ding [China] |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker |
---|---|---|---|
13:00-13:05 | 13:00-13:05 |
Introduction of Vanguard Multicenter committee and ongoing projects |
Yuji Soejima [Japan] |
13:05-13:20 | 13:05-13:20 |
Grade 3b-complictions in LDLT-D. (Adult) |
Koichiro Haruki [Japan] |
13:20-13:35 | 13:20-13:35 |
SFSS Grade B (Adult) |
Takeo Toshima [Japan] |
13:35-13:50 | 13:35-13:50 |
LDLT using interposition graft (Pediatric) |
Daniel Zamora-Valdés [Saudi Arabia] |
13:50-14:05 | 13:50-14:05 |
LDLT for MMA (Pediatric) |
Robert Minnee [Netherlands] |
14:05-14:20 | 14:05-14:20 |
SFSS Grade A |
Hye-Sung Jo [Republic of Korea] |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker |
---|---|---|---|
14:25-14:55 | 14:25-14:55 |
Pure Lap. Donor Right Hepatectomy |
Daniel Cherqui [France] |
14:55-16:25 | 14:55-16:25 |
How to lmplant Modified Right Lobe Graft having V5,V8, and Inferior Right |
Sung-Min Kim [Republic of Korea] |
16:25-17:55 | 16:25-17:55 |
Pure laparoscopic full-size liver transplantation in adult |
Wenrui Wu [China] |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
08:30-08:45 | 08:30-08:45 |
The safety and risk of immunosuppressant withdrawn after LTx |
Mark Muthiah [Singapore] | |
08:45-09:00 | 08:45-09:00 |
Mechanism behind immune tolerance after pediatric liver transplant |
Yuan Liu [China] | |
09:00-09:15 | 09:00-09:15 |
Donor-derived Regulatory DC infusion in Immune Tolerance: what we know |
Abhinav Humar [USA] | |
09:15-09:30 | 09:15-09:30 |
LT and immune suppression : another different view |
Jan Lerut [Belgium] | |
09:30-09:45 | 09:30-09:45 |
Q&A (10 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
09:40-09:55 | 09:40-09:55 |
Hypothermic machine perfusion in LTx |
Robert Porte [Netherlands] | |
09:55-10:10 | 09:55-10:10 |
Normothermic machine perfusion in LTx |
Markus Selzner [Canada] | |
10:10-10:25 | 10:10-10:25 |
The current status and future of ischemic-free organ transplantation |
Zhiyong Guo [China] | |
10:25-10:40 | 10:25-10:40 |
NRP in DCD dono |
Gabriel Oniscu [Sweden] | |
10:40-10:50 | 10:40-10:50 |
Q&A (10 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
11:30-12:00 | 11:30-12:00 |
围手术期胆汁淤积性肝病:早期识别与临床应对 |
Jun Liu [China] | |
11:30-12:00 | 11:30-12:00 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
13:00-13:15 | 13:00-13:15 |
When to call it futile in LT? |
Eleonora de Martin [France] | |
13:15-13:30 | 13:15-13:30 |
Clinical Management of Perioperative Infections in Liver Transplantation |
Li Zhuang [China] | |
13:30-13:45 | 13:30-13:45 |
What is the timing of CBP after liver transplantation in critical liver failure recipients? |
Huimin Yi [China] | |
13:45-14:00 | 13:45-14:00 |
Management of antibody mediated rejection after liver transplantation |
CHUAN SHEN [China] | |
14:00-14:15 | 14:00-14:15 |
Diagnosis, Treatment, and Research of Severe Peri-operative Infections in Liver Transplantation |
Wei Zhang [China] | |
14:15-14:30 | 14:15-14:30 |
Q&A (10 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
14:25-14:45 | 14:25-14:45 |
From Lab to Clinic: Translating Bioengineered Liver Organoids for Precision Modeling and Regeneration |
Yunfang Wang [China] | |
14:45-15:05 | 14:45-15:05 |
Progenitor Hepatocytes in Liver Disease: Therapeutic Potential and Translational Advances |
Hexin Yan [China] | |
15:05-15:25 | 15:05-15:25 |
Precise genome editing and the translational studies |
Dali Li [China] | |
15:25-15:45 | 15:25-15:45 |
Gene therapy to metabolic liver disease |
Taihua Yang [China] | |
15:45-15:55 | 15:45-15:55 |
Q&A (10 min) |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
08:00-08:15 | 08:00-08:15 |
Future directions of ABO-incompatible kidney transplantation |
Jiang Qiu [China] | |
08:15-08:30 | 08:15-08:30 |
Practice and exploration in managing recurrent kidney disease after transplantation |
Qiquan Sun [China] | |
08:30-08:45 | 08:30-08:45 |
Interpretation of the expert consensus on donor kidney quality standards |
Jiangqiao Zhou [China] | |
08:45-09:00 | 08:45-09:00 |
Observation of medium- and long-term outcomes of dual kidney transplantation in adults |
Weijie Zhang [China] | |
09:00-09:15 | 09:00-09:15 |
Discussant |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
09:15-09:30 | 09:15-09:30 |
Exploration and practice in xenotransplantation |
Gang Chen [China] | |
09:30-09:45 | 09:30-09:45 |
Advances in antibody research and application in kidney transplantation |
Gang Huang [China] | |
09:45-10:00 | 09:45-10:00 |
Establishment of kidney organoid platforms and prospects for large-scale application |
ruiming rong [China] | |
10:00-10:15 | 10:00-10:15 |
Multitarget therapy for antibody-mediated rejection after kidney transplantation |
Jin Zheng [China] | |
10:15-10:30 | 10:15-10:30 |
Discussant |
||
10:30-10:45 | 10:30-10:45 |
Coffee break |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
10:45-11:00 | 10:45-11:00 |
Multitarget therapy for antibody-mediated rejection after kidney transplantation |
Ming Zhang [China] | |
11:00-11:15 | 11:00-11:15 |
Practice of pediatric kidney transplantation |
Changxi Wang [China] | |
11:15-11:30 | 11:15-11:30 |
nduction management in living kidney transplantation |
Xubiao Xie [China] | |
11:30-11:45 | 11:30-11:45 |
Discussant |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
11:45-12:00 | 11:45-12:00 |
Use of mineralocorticoid receptor antagonists in kidney transplantation |
Jun Lin [China] | |
12:00-12:15 | 12:00-12:15 |
2025 ATC: International Hot Topics and New Advances in ABMR Prevention and Treatment in Kidney Transplantation |
Xianghui Wang [China] | |
12:15-12:30 | 12:15-12:30 |
Differentiation after Syndrome Differentiation: De Novo Malignancies After Transplantation |
Yun Miao [China] | |
12:30-12:45 | 12:30-12:45 |
Discussant |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker |
---|---|---|---|
12:45-13:15 | 12:45-13:15 |
Advances in clinical application of mTOR inhibitors in organ transplantation |
Xianghui Wang [China] |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
14:10-14:25 | 14:10-14:25 |
Several Issues in Organ Donation after Brain Death/Circulatory Death Determination |
Ying Cheng [China] | |
14:25-14:40 | 14:25-14:40 |
Assessment and application of ECD Kidney |
Chenguang Ding [China] | |
14:40-14:55 | 14:40-14:55 |
Experience Sharing on OPO Donation Practices in Jiangsu Province |
Guoyang Shao [China] | |
14:55-15:10 | 14:55-15:10 |
Technological Innovation, Institutional Reconstruction and Governance of Global Donation and Transplantation from Multiple Perspectives |
Wenshi Jiang [China] | |
15:10-15:25 | 15:10-15:25 |
Discussant |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
15:25-15:40 | 15:25-15:40 |
Normothermic Regional Machine Perfusion |
Zhiyong Guo [China] | |
15:40-15:55 | 15:40-15:55 |
Advances in Research on Renal Function Protection in Kidney Transplantation |
Yanfeng Wang [China] | |
15:55-16:10 | 15:55-16:10 |
How to Do a Good Job in Organ Donation from the Perspective of the Intensive Care Unit |
Hui Zhang [China] | |
16:10-16:25 | 16:10-16:25 |
Experience in Pediatric Organ Donation |
Wei Jia [China] | |
16:25-16:40 | 16:25-16:40 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
16:50-17:05 | 16:50-17:05 |
Maintenance and management of potential donors |
Chuanshen Xu [China] | |
17:05-17:20 | 17:05-17:20 |
TBD |
Gongtao Qian [China] | |
17:20-17:35 | 17:20-17:35 |
Common Legal and Ethical Issues of Organ Donation and Transplantation |
Ziqin Yao [China] | |
17:35-17:50 | 17:35-17:50 |
Enhancing Donation via Emergency and Critical Care |
Xiaogang Gao [China] | |
17:50-18:05 | 17:50-18:05 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
08:00-08:30 | 08:00-08:30 |
“Beyond Immunosuppression: Next-Generation Cell Therapies for T1DM(40 years anniversary of the invention of the Ricordi Chamber and Automated method)” |
Camillo Ricordi [USA] | |
08:30-08:50 | 08:30-08:50 |
Advances in the Diagnosis and Treatment of Type 1 Diabetes |
Linong Ji [China] | |
08:50-09:10 | 08:50-09:10 |
In Vitro Reconstruction and Application of Islet Tissue |
Xin Cheng [China] | |
09:10-09:30 | 09:10-09:30 |
Islet Transplantation Experience at Changzheng Hospital (2016–2025) |
Meng Guo [China] | |
09:30-09:45 | 09:30-09:45 |
Discussant |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
09:45-10:05 | 09:45-10:05 |
Clinical Report on Pediatric Heart Transplantation |
Zhongqun Zhu [China] | |
10:05-10:25 | 10:05-10:25 |
Technical Optimization of Lung Transplantation for Pulmonary Fibrosis |
chang chen [China] | |
10:25-10:45 | 10:25-10:45 |
Exploration and Considerations of Arterial and Venous Shunting Techniques in Donor Pancreas and Spleen |
Jiali Fang [China] | |
10:45-11:05 | 10:45-11:05 |
Small Intestine Transplantation for Intestinal |
Chaoxu Liu [China] | |
11:05-11:25 | 11:05-11:25 |
Discussant |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
11:25-11:45 | 11:25-11:45 |
Efforts in Disruptive Technology Innovation |
An Jin [China] | |
11:45-12:05 | 11:45-12:05 |
SLC Based Metabolic Pharmacology |
Ligong Chen [China] | |
12:05-12:25 | 12:05-12:25 |
Study on the Regulation of Macrophage Function by Cholesterol Metabolism |
红艳 王 [China] | |
12:25-12:45 | 12:25-12:45 |
Research and Development of Candidate Drugs Targeting ACLY for Hyperlipidemia and Metabolic-Associated Fatty Liver Disease |
jingya li [China] | |
12:45-13:05 | 12:45-13:05 |
Discussant |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
14:00-14:05 | 14:00-14:05 |
Address |
||
14:05-14:10 | 14:05-14:10 |
Group photo |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
14:10-14:30 | 14:10-14:30 |
"Development and Prospects of the Nursing Discipline at Shanghai Jiao Tong University School of Nursing" Nursing College, Shanghai Jiao Tong University |
Qiong Fang [China] | |
14:30-14:50 | 14:30-14:50 |
"Organ Donation and Allocation: Defending the Family-First Principle in China" Center for Health Reform and Development Studies, Xi’an Jiaotong University School of Public Health |
Mingxu Wang [China] | |
14:50-15:10 | 14:50-15:10 |
"Evidence-Based Clinical Practice of Exercise Rehabilitation for Kidney Transplant Recipients" The Third Xiangya Hospital of Central South University |
Jia Liu [China] | |
15:10-15:30 | 15:10-15:30 |
"Development and Continuous Improvement Strategies of Transplant Nursing Quality Standards" The First Affiliated Hospital of Xi’an Jiaotong University |
Dan Li [China] | |
15:30-15:50 | 15:30-15:50 |
Discussant |
||
15:40-15:50 | 15:40-15:50 |
Coffee break |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
---|---|---|---|---|
15:50-16:10 | 15:50-16:10 |
"Development and Practice of the Core Competency Training System for Transplant Specialist Nurses" Medical Application Technology College, Guangdong Lingnan Institute of Technology |
Guirong Ye [China] | |
16:10-16:30 | 16:10-16:30 |
"Postoperative Rehabilitation Management of Critically Ill Transplant Patients" Renji Hospital, Shanghai Jiao Tong University School of Medicine |
Zhen Chen [China] | |
16:30-16:50 | 16:30-16:50 |
"Case Management Practice for Hepatobiliary and Pancreatic Tumors" Beijing Tsinghua Changgung Hospital, Affiliated to Tsinghua University |
zhe Yan [China] | |
16:50-17:10 | 16:50-17:10 |
"Experience Sharing from Transplant Specialist Nurses in Singapore" Singapore General Hospital |
Chua Siew Huang [Singapore] | |
17:10-17:20 | 17:10-17:20 |
Discussant |